Experimental Evaluation in Identification of Kidney Cancer using Modified Learning Scheme

• Published in: 2024 International Conference on Advances in Computing, Communication and Applied Informatics (ACCAI) pp. 1 - 6
• Main Authors: Niranjana, S., Titus, Anita, Venkat, S, Arulanantham, D., Begum, A. Sumaiya
• Format: Conference Proceeding
• Language: English
• Published: IEEE 09.05.2024
• Subjects: Accuracy; Cancer detection; CNN; Computed tomography; Convolutional Neural Network; Convolutional neural networks; Deep learning; Disease Identification; Kidney Cancer; LMKCD; Location awareness; Modified Learning; Surgery
• ISBN: 9798350389432
• DOI: 10.1109/ACCAI61061.2024.10601727

The most critical part of dealing with kidney cancer is making a diagnosis, which necessitates pinpoint accuracy in identifying tumour locations and categorizing tumour types. Furthermore, tumour volume and relative severity inform the selection of suitable surgical techniques for malignant situations. The use of contrast-enhanced computed tomography (CT) images for the localization, quantification, and stratification of kidney tumours has been suggested as a strategy based on machine learning in recent years. Nevertheless, prior research has mainly ignored the possibility of enhancing diagnosis and guiding surgical procedures through the integration of patient information with clinical imaging. One of the most prevalent types of cancer in the world is kidney cancer. Size or volume of tumour, cancer type and stage, etc. is just a few of the variables that could affect the accuracy of a diagnosis, which is an essential part of caring for patients with kidney cancer. Clinicians frequently lack convincing evidence to support the choice to perform partial or radical kidney surgery for malignant tumours. While in less severe cases radical nephrectomy may unnecessarily put people on dialysis for the rest of their lives or need a kidney transplant in the future, in cases when removal of just part of the kidney is necessary, the patient may die of cancer. This paper introduces a new learning scheme, Learning Model for Kidney Cancer Detection (LMKCD), to intelligently identify the disease. To evaluate its efficiency, it is cross-validated with an existing deep learning model, Convolutional Neural Network (CNN).